CD40 and neoplasm: For example, Amini et al. reported that significant CD40 hypermethylation was observed in breast cancer specimens in relation to non-tumor adjacent specimens, which was strongly associated with the clinical stage of malignancy, suggesting that CD40 DNA methylation in breast cancers is a novel epigenetic biomarker [32].